Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNeuropharmacology

The Role of Presenilin-1 in the Excitotoxicity of Ethanol Withdrawal

Marianna E. Jung, Daniel B. Metzger and Hriday K. Das
Journal of Pharmacology and Experimental Therapeutics September 2016, 358 (3) 516-526; DOI: https://doi.org/10.1124/jpet.116.233361
Marianna E. Jung
Institute for Health Aging, Center for Neuroscience Discovery (M.E.J., D.B.M., H.K.D.), and Institute of Cancer Research (H.K.D.), University of North Texas Health Science Center, Fort Worth, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel B. Metzger
Institute for Health Aging, Center for Neuroscience Discovery (M.E.J., D.B.M., H.K.D.), and Institute of Cancer Research (H.K.D.), University of North Texas Health Science Center, Fort Worth, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hriday K. Das
Institute for Health Aging, Center for Neuroscience Discovery (M.E.J., D.B.M., H.K.D.), and Institute of Cancer Research (H.K.D.), University of North Texas Health Science Center, Fort Worth, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 358 no. 3 516-526
DOI 
https://doi.org/10.1124/jpet.116.233361
PubMed 
27278235

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received March 4, 2016
  • Accepted May 27, 2016
  • Published online August 15, 2016.

Article Versions

  • Earlier version (June 8, 2016 - 07:31).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Marianna E. Jung,
  2. Daniel B. Metzger, and
  3. Hriday K. Das
  1. Institute for Health Aging, Center for Neuroscience Discovery (M.E.J., D.B.M., H.K.D.), and Institute of Cancer Research (H.K.D.), University of North Texas Health Science Center, Fort Worth, Texas
  1. Address correspondence to:
    Marianna E. Jung, Institute for Health Aging, Center for Neuroscience Discovery, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107. E-mail: Marianna.Jung{at}unthsc.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2016 to April 2021

AbstractFullPdf
Jun 2016117152
Jul 201634127
Aug 20162861133
Sep 20167658
Oct 20163065
Nov 201622118
Dec 20161233
Jan 20172134
Feb 20171021
Mar 20173386
Apr 20172223
May 20171744
Jun 20171943
Jul 20172212
Aug 20171763
Sep 20171144
Oct 20171106
Nov 20172196
Dec 20171110
Jan 20183194
Feb 20181115
Mar 20184162
Apr 20184194
May 20183162
Jun 20182186
Jul 20181144
Aug 2018291
Sep 2018281
Oct 20184103
Nov 2018266
Dec 20181104
Jan 2019021
Feb 2019283
Mar 2019066
Apr 20190156
May 2019133
Jun 2019297
Jul 2019276
Aug 2019193
Sep 20190179
Oct 20190113
Nov 20192137
Dec 20191187
Jan 2020187
Feb 2020275
Mar 2020275
Apr 2020031
May 2020067
Jun 20200107
Jul 202002312
Aug 2020396
Sep 2020064
Oct 20201198
Nov 20200117
Dec 2020275
Jan 20211146
Feb 2021675
Mar 202171213
Apr 2021155

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 358 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 358, Issue 3
1 Sep 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Presenilin-1 in the Excitotoxicity of Ethanol Withdrawal
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNeuropharmacology

Presenilin-1 and Ethanol Withdrawal

Marianna E. Jung, Daniel B. Metzger and Hriday K. Das
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 516-526; DOI: https://doi.org/10.1124/jpet.116.233361

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNeuropharmacology

Presenilin-1 and Ethanol Withdrawal

Marianna E. Jung, Daniel B. Metzger and Hriday K. Das
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 516-526; DOI: https://doi.org/10.1124/jpet.116.233361
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CVN424, a novel GPR6 inverse agonist for Parkinson's disease
  • Methylone Brain Concentrations and Pharmacodynamic Effects
  • Oxysterols and Ethanol
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics